HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiò, A. Articles by the Piemonte and Valle d’Aosta Register for Guillain-Barré Syndrome Search for Related Content PubMed Articles by Chiò, A. Articles by the Piemonte and Valle d’Aosta Register for Guillain-Barré Syndrome, Related Collections All Neuromuscular Disease Guillain-Barre syndrome All epidemiology Prevalence studies Incidence studies

Guillain-Barré syndrome

A prospective, population-based incidence and outcome survey

*See the Appendix on page 1149 for a list of members of the Piemonte and Valle d’Aosta Register for GBS (PARGBS).
From the Department of Neuroscience, University of Turin (Drs. Chiò, Cocito, Mutani, and Giordana); and San Giovanni Battista Hospital, Turin (Drs. Chiò, Cocito, and Mutani); the Division of Neurology, "A. Avogadro" University, Novara (Dr. Leone); San Luigi Hospital, Orbassano (Dr. Giordana); and the Department of Neurological Rehabilitation, Fondazione S. Maugeri, Clinical del Lavoro e della Riabilitazione, IRCCS, Scientific Institute of Veruno (Dr. Mora), Italy.

Address correspondence and reprint requests to Dr. Adriano Chiò, Department of Neuroscience, Via Cherasco 15, I-10126 Torino, Italy; e-mail: achio{at}usa.net

Objective: The authors evaluated the incidence and long-term prognostic factors of Guillain-Barré syndrome (GBS) in a prospective, population-based study.

Methods: Patients with GBS diagnosed according to National Institute of Neurological and Communicative Disorders and Stroke criteria in the 2-year period 1995 to 1996 in two Italian regions were prospectively followed up for 2 years after onset of GBS.

Results: A total of 120 patients were found, corresponding to a crude annual incidence rate of 1.36/100,000 population (95% CI, 1.13 to 1.63). A total of 7 (5.8%) patients, all but one with axonal or mixed EMG pattern, died acutely within 30 days from the onset of the disease. Acute mortality was due to respiratory involvement and intensive care unit complications. In multivariate analysis, a worse 2-year outcome (Hughes score 2) was related to a higher Hughes grade at nadir, axonal or mixed EMG, age 50 years, and absence of respiratory infections preceding GBS. The persistence of disability 2 years after the acute phase was related to axonal involvement and a worse status at nadir.

Conclusions: After adjustment to US population, the incidence rates for GBS from different countries showed no significant differences. Both acute mortality and long-term disability in GBS seem to be related to an axonal involvement and a Hughes grade 2 at nadir.

This article has been cited by other articles:

				N. Khazeni, D. W. Hutton, A. M. Garber, and D. K. Owens Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic Ann Intern Med, October 5, 2009; (2009) 0000605-200912150-00156v1. [Abstract] [Full Text]

				N. Khazeni, D. W. Hutton, A. M. Garber, N. Hupert, and D. K. Owens Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009 Ann Intern Med, October 5, 2009; (2009) 0000605-200912150-00157v1. [Abstract] [Full Text]

				K Kuitwaard, R van Koningsveld, L Ruts, B C Jacobs, and P A van Doorn Recurrent Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 56 - 59. [Abstract] [Full Text] [PDF]

				A. Alshekhlee, Z. Hussain, B. Sultan, and B. Katirji Guillain-Barre syndrome: Incidence and mortality rates in US hospitals Neurology, April 29, 2008; 70(18): 1608 - 1613. [Abstract] [Full Text] [PDF]

				A Chio, D Cocito, E Bottacchi, C Buffa, M Leone, F Plano, R Mutani, A Calvo, and the PARCIDP Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1349 - 1353. [Abstract] [Full Text] [PDF]

				R. A. Hughes, J. Charlton, R. Latinovic, and M. C. Gulliford No association between immunization and guillain-barre syndrome in the United kingdom, 1992 to 2000. Arch Intern Med, June 26, 2006; 166(12): 1301 - 1304. [Abstract] [Full Text] [PDF]

				A. Forsberg, R. Press, U. Einarsson, J. de Pedro-Cuesta, and L. W. Holmqvist Disability and health-related quality of life in Guillain-Barre syndrome during the first two years after onset: a prospective study Clinical Rehabilitation, August 1, 2005; 19(8): 900 - 909. [Abstract] [PDF]

				R. A. C. Hughes, E. F. M. Wijdicks, E. Benson, D. R. Cornblath, A. F. Hahn, J. M. Meythaler, J. T. Sladky, R. J. Barohn, and J. C. Stevens Supportive Care for Patients With Guillain-Barre Syndrome Arch Neurol, August 1, 2005; 62(8): 1194 - 1198. [Abstract] [Full Text] [PDF]

				A Hiraga, M Mori, K Ogawara, S Kojima, T Kanesaka, S Misawa, T Hattori, and S Kuwabara Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 719 - 722. [Abstract] [Full Text] [PDF]

				C. D. de la Cour and J. Jakobsen Residual neuropathy in long-term population-based follow-up of Guillain-Barre syndrome Neurology, January 25, 2005; 64(2): 246 - 253. [Abstract] [Full Text] [PDF]